Tag: PUBLIC HEALTH INFORMATION

Utah’s Race-Based Allocation of COVID-19 Drugs Wasn’t Cleared by Lawyers: Emails

Legal scholars warned officials in Utah that using race to determine which patients could get crucial COVID-19 drugs was likely illegal but the state kept the system in place for months afterward, newly released emails show. Utah was one of multiple states to develop systems that gave people who weren’t white a better chance of…


FDA Investigating Reports of COVID Relapses Following Use of Pfizer’s Pill

The U.S. Food and Drug Administration (FDA) is investigating reports of relapses among people who took Pfizer’s COVID-19 pill. The FDA “is evaluating the reports of viral load rebound after completing paxlovid treatment and will share recommendations if appropriate,” an agency spokesperson told The Epoch Times in an email. In a recent preprint case report,…


Pfizer Says Its COVID-19 Pill Paxlovid Fails to Prevent Symptomatic Infection of Household Members

Pfizer announced Friday that a recent large, late-stage trial found that its COVID-19 antiviral pill, Paxlovid, failed at preventing symptomatic infection of people living with a person who has the disease. The trial enrolled 2,957 participants aged 18 and older who live in the same household as another person who has COVID-19 with symptoms. They were given either…


Increase in Reactivated Viruses Following COVID-19 Booster Shots: Dr. Richard Urso

Some viruses, after initial infection, remain latent in the body for a lifetime and may reactivate to cause infection again or a different condition. These kinds of latent viruses are being reactivated in a large number of people following their booster COVID-19 shots, causing symptoms of long COVID and other health conditions, according to Dr….


Vitamin D Supplementation Is Effective in Preventing COVID-19, Study Suggests

Vitamin D supplementation can help prevent COVID-19 without serious adverse events, regardless of the individual’s vitamin D status, a study suggests. The peer-reviewed study, published in the Archives of Medical Research, enrolled 321 frontline health care workers from four hospitals in Mexico City, who all tested negative for COVID-19 at the start of the study. “The results of…


No Documents to Support CDC’s Claims That COVID-19 Vaccines Do Not Integrate Into DNA: Advocacy Group

The Centers for Disease Control and Prevention (CDC) did not rely on any documents for its claims that the COVID-19 vaccines do not alter or integrate into people’s genetic material, according to an advocacy group for vaccine and pharmaceutical safety and the right to informed consent. The Informed Consent Action Network (ICAN) filed a Freedom…


Reports of Rare Vulvar Ulcers in Adolescent Girls Following Pfizer COVID-19 Injections

Cases of rare vulvar ulcers have been diagnosed in adolescent girls after receiving a second dose of the Pfizer messenger RNA (mRNA) shot, according to the April edition of the Journal of Pediatric & Adolescent Gynecology. Six cases of adolescent girls ages 12 to 16 developing painful genital ulcers within four days of their second…


Two COVID-19 Treatments Show Promise in Trials

Two COVID-19 treatments that have not yet been authorized for administration were successful in clinical trials, the companies behind the drugs announced on April 11. A pill developed to attack cancer was successful in curbing deaths among COVID-19 patients in hospitals deemed high risk for Acute Respiratory Distress Syndrome, according to U.S.-based Veru Inc., the maker…


US Regulators Say Current COVID Vaccines Not ‘Well-Matched’ Against BA.2 Subvariant

The three COVID-19 vaccines authorized for use in the United States are not “well-matched” against the BA.2 virus subvariant, which has recently been estimated to have become dominant in the country, U.S. regulators said on April 6. “While currently available vaccines are not well-matched to the dominant circulating variant—which is the Omicron BA.2 sublineage—we do…


FDA Floats Moving COVID-19 Vaccines to Flu-Like Model

Food and Drug Administration (FDA) officials have proposed a future model for developing new COVID-19 vaccines that would be built on the approach to creating influenza vaccines. Accumulating data suggest the current COVID-19 vaccines, based on a virus strain that is now generations old, “may need to be updated at some point to ensure the…